Study of changes in serum iron, albumin and calcium levels in smear positive pulmonary tuberculosis patients compared with healthy individuals before starting Directly Observed Treatment, Short course
DOI:
https://doi.org/10.3329/mediscope.v9i1.58524Keywords:
Pulmonary tuberculosis, smear positive, serum iron, serum albumin, serum calciumAbstract
Background: Tuberculosis one of the most important infectious diseases throughout the world. Bangladesh is a highly populated country and a significant amount of mortality and morbidity is caused by tuberculosis, especially pulmonary tuberculosis.
Objectives: To evaluate the levels of serum iron, albumin and calcium in smear positive pulmonary tuberculosis (PTB) patients before starting Directly Observed Treatment, Short course (DOTS) regimen.
Methods: This was a cross-sectional study. A total of 100 subjects were included in this study. Among them, 50 were smear positive PTB patients denoted as case group and 50 were apparently healthy individuals denoted as control group. Biochemical tests were carried out in the Department of Biochemistry, Mymensingh Medical College. All the statistical analyses were performed by SPSS version 21. Results were evaluated by using Student’s t-test.
Results: The study revealed that mean values of serum iron were 128.24±13.20 μg/dl and 86.13±24.56 μg/dl in control and case group respectively, and the difference between two groups were highly significant (p <0.001). The mean serum albumin level was lower in case group when compared to control group. The mean values of serum albumin were 4.1±0.33 gm/dl and 3.5±0.31 gm/dl in control and case group respectively, and the difference between two groups were highly significant (p <0.001). The mean values of serum calcium were 2.33±0.19 mmol/L and 2.5±0.16 mmol/L in control group and case group respectively. Serum calcium level was adjusted by serum albumin concentration. The analysis showed that, the difference in mean serum calcium levels between two groups were highly significant (p <0.001)
Mediscope 2022;9(1): 25-29
Downloads
27
36
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 PS Biswas, JZ Tuli, RA Ruba, T Rahman, F Hasanat, A Azad
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Mediscope agree to the following terms that:
- Authors retain copyright and grant Mediscope the right of first publication of the work.
Articles in Mediscope are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.